Article Abstract
Letter to the Editor
Sir: Isonicotinylhydrazide, also known as isoniazid, is awell-known agent for treatment of mycobacterial infections. Itis also used for prevention of tuberculosis, given 300 mg/dayfor a period of at least 6 months. In vivo studies, usingbenzylamine as substrate, have demonstrated that isoniazid intherapeutic doses inhibits plasma monoamine oxidase (MAO)with no significant effect on platelet MAO.
From the Editors
Are you a healthcare provider?
Add your NPI to personalize your JCP experience.
Download Free PDF
This PDF is free for all visitors!
